Truist Securities analyst Richard Newitter raised the price target on Globus Medical (NYSE: GMED) to $79.00 (from $78.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Globus Medical (GMED) PT Raised to $78 at RBC CapitalAugust 7, 2024 7:00 AM Wells Fargo Upgrades Globus Medical (GMED) to OverweightAugust 7, 2024 5:24 AM Globus Medical (GMED) PT Raised to $100 at Roth/MKMAugust 7, 2024 5:17 AM Form 10-Q GLOBUS MEDICAL INC For: Jun 30August 6, 2024 5:09 PM Globus Medical (GMED) Tops Q2 EPS by 7c, provides guidanceAugust 6, 2024 4:39 PM Form 8-K GLOBUS MEDICAL INC For: Aug 06August 6, 2024 4:21 PM Globus Medical Reports Second Quarter 2024 ResultsAugust 6, 2024 4:15 PM